启函生物Co-founded in 2017 by two pioneers in genome editing technology, Qihan Biotech has world-leading capabilities in multiplexable genome editing as well as vast experience in Immune shielding. We apply these tools in both human stem cells and animal germline cells to deliver novel immune-privileged cell and organ therapies.
健培科技致力于医学大数据人工智能产品的国家高新技术企业。公司始终秉持“打造世界领先的机器人医生”的愿景,专注医疗健康领域的人工智能服务与创新,成功打造了医疗AI领域现象级产品——“啄医生”,形成了“大数据+云计算”与“互联网+人工智能”一体化的智慧医疗服务生态产品体系。